Malabsorption News

Patients who had previously been prescribed antisecretory medications, including proton pump inhibitors and histamine-2 receptor antagonists, were at increased risk for developing celiac disease in a recent study.

Neither mucosal inflammation nor basophil activation occurred after gliadin incubation in duodenal mucosal samples collected from patients with nonceliac gluten sensitivity compared with samples obtained from patients with celiac disease in a recent study.

Patients who sustain head trauma are at slightly increased risk for developing celiac disease, according to recent results.

Patients with IBS and visceral hypersensitivity are more likely to experience lactose intolerance symptoms, particularly bloating, according to recent results.

Patients with nonceliac gluten sensitivity and IBS benefited from diets low in fermentable, poorly absorbed, short-chain carbohydrates but did not experience symptom changes after gluten introduction in a recent study.

Patients with celiac disease were at increased risk for lymphoproliferative malignancy, but this risk was greater among patients with persistent villous atrophy, according to recent results.

The national prevalence of nonceliac gluten sensitivity may be lower than initially believed, recent study results suggest.

The FDA has published a standard definition for the phrase “gluten-free,” to be applied to voluntary food labeling in the United States, according to a press release.

Caucasians with iron deficiency are at increased risk for developing celiac disease, while iron-deficient non-Caucasians are not, according to recent results.

Patients with celiac disease may be more likely to develop early atherosclerosis, but a gluten-free diet has the potential to mitigate this increased risk, according to recent results.